CL2010000695A1 - Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition. - Google Patents

Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition.

Info

Publication number
CL2010000695A1
CL2010000695A1 CL2010000695A CL2010000695A CL2010000695A1 CL 2010000695 A1 CL2010000695 A1 CL 2010000695A1 CL 2010000695 A CL2010000695 A CL 2010000695A CL 2010000695 A CL2010000695 A CL 2010000695A CL 2010000695 A1 CL2010000695 A1 CL 2010000695A1
Authority
CL
Chile
Prior art keywords
less
cyclosporine
glycerin
treat
water
Prior art date
Application number
CL2010000695A
Other languages
Spanish (es)
Inventor
Mwilliam Francis Stringer
Original Assignee
Alcon Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66221240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010000695(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Pharmaceuticals Ltd filed Critical Alcon Pharmaceuticals Ltd
Priority to CL2010000695A priority Critical patent/CL2010000695A1/en
Publication of CL2010000695A1 publication Critical patent/CL2010000695A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición oftálmica acuosa que comprende una ciclosporina, glicerina y agua, donde la composición contiene menos de 0,3% de cloruro de sodio y menos de 0,04% de metabisulfito de sodio; y uso para tratar una condición ocular.Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition.

CL2010000695A 2010-06-25 2010-06-25 Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition. CL2010000695A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2010000695A CL2010000695A1 (en) 2010-06-25 2010-06-25 Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2010000695A CL2010000695A1 (en) 2010-06-25 2010-06-25 Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition.

Publications (1)

Publication Number Publication Date
CL2010000695A1 true CL2010000695A1 (en) 2011-05-13

Family

ID=66221240

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2010000695A CL2010000695A1 (en) 2010-06-25 2010-06-25 Aqueous ophthalmic composition comprising a cyclosporine, glycerin and water, where the composition contains less than 0.3% sodium chloride and less than 0.04% sodium metabisulfite; and use to treat an eye condition.

Country Status (1)

Country Link
CL (1) CL2010000695A1 (en)

Similar Documents

Publication Publication Date Title
CL2014002564A1 (en) Water treatment compositions comprising a coagulant containing aluminum and a natural non-derived polysaccharide, wherein the ratio between the polysaccharide and the coagulant is between 1:10 to 1: 100; and methods of use.
NI201000093A (en) TOWEL TO WEAR
CL2010001406A1 (en) Ophthalmic pharmaceutical composition comprising povidone iodine, and a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial, an anti-allergic or an anti-glaucoma compound; and method to preserve the composition.
CR20110163A (en) USE OF DITIINE-TETRACARBOXAMIDS TO FIGHT FITOPATOGEN FUNGI
BR112015000520A2 (en) stable lipase thickening agent
CL2013001471A1 (en) Composition comprising at least one n-acetyl-lactosamine, at least one sialylated oligosaccharide and at least one fucosylated oligosaccharide and a hydrolyzate comprising partially and / or completely hydrolyzed proteins; and its use for the prevention and / or treatment of skin conditions and skin diseases.
GT201200276A (en) COMBINATIONS OF ACTIVE COMPOUNDS
AR082381A1 (en) AQUOUS COMPOSITION CONTAINING BROMHEXINE
MX2019001877A (en) Ophthalmic pharmaceutical compositions and uses relating thereto.
AR089268A1 (en) WATER COMPOSITIONS FOR ORAL CARE
CL2013001589A1 (en) Use of an emulsion comprising 0.08% by weight or less of antimicrobial essential oil, acacia gum and water to provide an antimicrobial effect in an aqueous composition; process to improve the antimicrobial effect of an antimicrobial essential oil; and aqueous composition comprising an antimicrobial emulsion.
TR201905683T4 (en) Ophthalmic formulation and method for erosive presbyopia.
CL2009000573A1 (en) Injectable intraocular pharmaceutical composition in the form of an aqueous suspension that does not contain a preservative, consisting of triamcinolone acetonide, sodium carboxymethylcellulose, 0.002-0.02% polysorbate 80, chlorides to adjust the tonicity, buffering agent, water and adjusting agent of ph; use to treat the eye.
EA201201239A1 (en) A composition comprising as active ingredients L-CARNITINE IN COMBINATION WITH hydroxykynurenine-O-BETA-DL-glucoside FOR PREVENTING AND / OR TREATING PATHOLOGIES eyes caused by ultraviolet radiation
EA201600442A1 (en) SOFT PHARMACEUTICAL COMPOSITION ON WATER BASIS CONTAINING TAPENTADOL
MY170307A (en) Polymer-based dialysate
MX2010002999A (en) Sunscreen compositions with low eye-sting and high spf.
MX373389B (en) SULFONAMIDE DERIVATIVE AND ITS PHARMACEUTICAL USE.
ES2538551R2 (en) Ophthalmic composition for the correction of presbyopia
WO2015028745A3 (en) Cosmetic composition comprising a sulphonic polymer, a hydrophobic polysaccharide and a silicone surfactant
NI201400065A (en) PREPARATIONS INCLUDING AMORPHOUS EMODEPSIDE
CO6541623A2 (en) ORAL REHYDRATION SOLUTIONS UNDERSTANDING DEXTROSA
UY33153A (en) TYPICAL OPTIMAL FORMULATION OF PEPTIDES
PY1361141A (en) TEMPERATURE-STABLE AQUEOUS COMPOSITIONS OF CLOQUINTOCETMEXIL
AR088016A1 (en) ABSORBENT ARTICLE